-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/omega-3-maternity_research-protocol.pdf
May 18, 2015 - Source: www.effectivehealthcare.ahrq.gov
Published online: May 18, 2015
24
#39 cod AND ('liver … '/exp OR liver) AND oil* OR codliver AND oil* OR marine AND oil* OR
marine AND fat
#40 'salmon'/exp … 63 (walnut$ or butternut$ or soybean$ or pumpkin seed$).mp.
64 (fish adj2 oil$).mp.
65 (cod liver … butternut*or soybean* or "pumpkin seed" or pumpkinseed*:ti,ab,kw
#12 "cod liver … and (oil or oils) ) OR walnut* or butternut*or
soybean* or "pumpkin seed" or pumpkinseed* OR "cod liver
-
www.ahrq.gov/sites/default/files/2024-01/lambert2-report.pdf
January 01, 2024 - guidelines about 72% of the time when they prescribed metformin as first-line therapy, adjusting for any liver … The liver function markers ALT/AST were perfectly correlated with the metformin prescription and,
hence … Patients with impaired liver function never got metformin.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
October 27, 2017 - The HAS-BLED (H=hypertension,
A=abnormal renal/liver function, S=stroke, B=bleeding history or predisposition … glomerular filtration rate;
ESRD = end-stage renal disease; HAS-BLED = hypertension, abnormal renal/liver … Evidence-based Practice Center
ESRD end-stage renal disease
HAS-BLED hypertension, abnormal renal/liver
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2008
December 30, 2013 - older age, hypothyroidism, surgery or trauma, heavy exercise, excessive alcohol intake, and renal or liver … Increased liver transaminases (prevalence 2% to 5%) is a common side effect of statins and is more prevalent … in those with underlying liver disease.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/6desD2XJCQKF8ZDPMS-NU_
July 01, 2005 - Prevalence of fatty liver in Japanese
children and relationship to obesity. … Liver involvement in obese
children. … Ultrasonography and liver
enzyme levels at diagnosis and during
follow-up in an Italian population. … mean = 208%
IBW
6.8 (calc)
1 (calc)
32
5
Mallory,
198918
Nonalcoholic fatty
liver
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Severity.PDF
January 01, 2006 - comorbidity measure: Hypothyroidism 8074825 0 0.00 1.00 0.07 0.25
CM_LIVER : AHRQ comorbidity measure: Liver … Wednesday, May 7, 2008 4
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of
Total
1: LIVER … DISORDERS 13744 0.17
280: ALCOHOLIC LIVER DISEASE 14070 0.17
281: MALIGNANCY OF HEPATOBILIARY SYSTEM … OF LIVER, EX MALIGNANCY W MCC 11259 0.14
2070: DISORDERS OF THE BILIARY TRACT WO CC 10610 0.13
2071 … &/OR INTESTINAL TRANSPL WO CC 34 0.00
4801: LIVER &/OR INTESTINAL TRANSPL W CC 286 0.00
4802: LIVER
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2005_SummaryStats_SEVERITY.PDF
January 01, 2005 - comorbidity measure:
Hypothyroidism 7995048 0 0.00 1.00 0.06 0.25
CM_LIVER : AHRQ comorbidity measure: Liver … Thursday, June 14, 2007
APRDRG Frequency
Percent
of
Total
279: HEPATIC COMA & OTHER MAJOR ACUTE LIVER … DISORDERS 13466 0.17
280: ALCOHOLIC LIVER DISEASE 13816 0.17
281: MALIGNANCY OF HEPATOBILIARY SYSTEM … OF LIVER, EX MALIGNANCY W MCC 11040 0.14
2070: DISORDERS OF THE BILIARY TRACT WO CC 10121 0.13
2071 … &/OR INTESTINAL TRANSPL WO CC 50 0.00
4801: LIVER &/OR INTESTINAL TRANSPL W CC 432 0.01
4802: LIVER
-
psnet.ahrq.gov/node/49804/psn-pdf
September 01, 2017 - Burden of gastrointestinal, liver, and pancreatic diseases in the
United States. … Dig Liver Dis. 2012;44:723-728. [go to PubMed]
7. Podugu A, Tandon K, Castro FJ.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ykFSVS29KAwKzFWSXAVoMY
June 01, 2009 - infections
increase long-term morbidity and mortality by predis-
posing infected persons to cirrhosis of the liver … and liver
cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
September 02, 2016 - mackerel OR herring OR tuna OR halibut OR seaweed OR
anchovy OR anchovies OR sardine OR sardines OR cod liver … (cod liver oil$ or codliver oil$ or marine oil$ or marine fat$).mp. … (cod liver oil$ or codliver oil$ or marine oil$ or marine fat$).mp. … menhaden OR fish AND oil*) OR (walnut* OR butternut* OR
soybean* OR pumpkin AND seed*) OR (cod AND liver … menhaden OR fish AND oil*) OR (walnut* OR butternut* OR
soybean* OR pumpkin AND seed*) OR (cod AND liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
December 31, 2013 - Drug Class Mechanism Example Drugs
Biguanide Suppresses glucose production
by the liver
§ Metformin … L
iv
er
in
ju
ry
The risk of liver injury was similar for
thiazolidinediones and sulfonylureas. … The rates of liver injury were similar between
thiazolidinediones and metformin. … (Insufficient) New Evidence:
L
iv
er
in
ju
ry
The risk of liver injury was similar for thiazolidinediones … (High)
New Evidence:
The rates of liver injury were similar between thiazolidinediones and
metformin
-
digital.ahrq.gov/sites/default/files/docs/citation/ereferralimplementationreportfinal.pdf
February 01, 2012 - 0.9
Gastroenterology 229 14.2 50.0 35.4 10.1 25.3 0.4
Hematology 34 10.5 50.2 38.9 7.5 31.4 0.5
Liver … referrals that were “Not Initially
Scheduled” ranged between 9 percent for neurology to 67 percent for liver … proportion of electronic referrals “Never Scheduled” ranged from 4 percent for neurology to
53 percent for liver … MAR09
MAY09
JU
L0
9
Month
D
ay
s
Cardiology
Chest
Endocrinology
Gastroenterology
Hematology
Liver … Liver clinic,
night and day. It used to be 5 months to a year, now it's about 1 to 2 months.”
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
May 01, 2013 - and safety
of pharmacologic and mechanical strategies to prevent
VTE in hospitalized patients with liver … Burns (KQ 3)
• Thrombocytopenia and/
or prolonged international
normalized ratio secondary to
liver … We did not identify any studies among patients with liver
failure. … Patients With Liver Disease
We found no studies that directly addressed the
comparative effectiveness … and safety of pharmacologic
strategies for VTE prevention in patients with liver disease.
-
hcup-us.ahrq.gov/reports/statbriefs/sb120.pdf
September 01, 2011 - Four percent
involved acute renal or liver failure, an increase of 127 percent since 1999 2000. … Deficiency and other anemia
377
(7%)
425
(7%)
857
(12%)
628
(11%)
66%***
Acute renal or liver … : Deficiency and other anemia
83: Epilepsy; convulsions
106: Cardiac dysrhythmias
151: Other liver
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-medication-safety.pdf
April 30, 2025 - Assess appropriate medication safety monitoring by
recommended laboratory tests (e.g., liver function … 2015
$2,495,705
Final Report
Purpose: (1) Evaluate the incidence and outcomes of drug-induced acute liver … injury patients at increased risk of ALF; and (3)
compare the risk of severe acute liver injury and … risk prediction
model with platelet count and total bilirubin identified patients with drug-induced liver … Acute liver
injury occurred rarely within the first year of modern antiretroviral initiation, but protease
-
psnet.ahrq.gov/web-mm/privacy-or-safety
December 01, 2011 - the Other Cheek
March 1, 2012
WebM&M Cases
Liver
-
psnet.ahrq.gov/web-mm/palliative-care-comfort-vs-harm
December 04, 2016 - patients with renal failure, hydromorphone is an acceptable choice as it is mainly metabolized by the liver
-
psnet.ahrq.gov/sites/default/files/2022-02/final_cme_reviewed_spotlight_loss_of_trust_and_a_missed_diagnosis_02.14.20221_-_clean_-_revised.pdf
January 01, 2022 - a diagnosis of lung cancer, and magnetic
resonance imaging (MRI) showed signs of metastases to the liver
-
psnet.ahrq.gov/node/50754/psn-pdf
December 18, 2019 - The Case
A 63-year-old woman with a history of liver transplantation secondary to hepatitis C, low back
-
psnet.ahrq.gov/node/49611/psn-pdf
October 01, 2010 - fluoxetine, paroxetine, fluvoxamine, nefazodone) have potent inhibitory effects on P-450
isoenzymes, the liver